Linda Härmark

发表的论文24 篇，按出版时间

1. 1
   Toward a Framework for Case Identification in Pharmacovigilance: Not All Reports are Created EqualDrug Safety20260
2. 2
   Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of ExcellenceDrug Safety20261
3. 3
   Current Challenges in Monitoring the Safety and Utilisation of the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A UK PerspectiveDrug Safety20260
4. 4
   Development of a multivariate prediction model to identify individual case safety reports which require clinical reviewPharmacoepidemiology and Drug Safety202216
5. 5
   Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder AnalysisDrug Safety202221
6. 6
   Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UKDrug Safety202114
7. 7
   Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION studyExpert Opinion on Drug Safety202122
8. 8
   Insight in the safety profile of antidiabetic agents glucagon‐like peptide‐1 agonists and dipeptidyl peptidase‐4 inhibitors in daily practice from the patient perspectivePharmacoepidemiology and Drug Safety20204
9. 9
   Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the NetherlandsDrug Safety20201
10. 10
    Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New ZealandDrug Safety20204